Seeing Is Believing
Healthcare - Sector
RCUS is currently covered by 12 analysts with an average price target of $34. This is a potential upside of $9.59 (39.29%) from yesterday's end of day stock price of $24.41.
Arcus Biosciences's activity chart (see below) currently has 166 price targets and 157 ratings on display. The stock rating distribution of RCUS is 77.78% BUY and 22.22% HOLD.
Analysts average stock forecasts to be materialized ratio is 45.38% with an average time for these price targets to be met of 264.79 days.
Highest price target for RCUS is $49, Lowest price target is $16, average price target is $34.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 30-Sep-2026. First documented stock forecast 09-Apr-2018.
Currently out of the existing stock ratings of RCUS, 21 are a BUY (77.78%), 6 are a HOLD (22.22%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Oct-2018
$43
$18.59 (76.16%)
$43
11 days ago
(30-Sep-2026)
8/19 (42.11%)
$17.17 (66.47%)
650
Hold Since 06-Aug-2026
$26
$1.59 (6.51%)
$23
2 months 5 days ago
(06-Aug-2026)
6/6 (100%)
$-2.33 (-8.22%)
208
Buy Since 03-Jun-2025
$45
$20.59 (84.35%)
$32
2 months 21 days ago
(20-Jul-2026)
7/10 (70%)
$16.83 (59.74%)
244
Hold Since 11-May-2026
$22
$-9 (-29.03%)
$20
5 months ago
(11-May-2026)
4/10 (40%)
$-2.86 (-11.50%)
195
Buy Since 07-May-2026
$34
$9.59 (39.29%)
$28
5 months 4 days ago
(07-May-2026)
2/3 (66.67%)
$9.22 (37.21%)
160
What is RCUS (Arcus Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on RCUS (Arcus Biosciences)?
Which analyst has the most public recommendations on RCUS (Arcus Biosciences)?
Which analyst is the currently most bullish on RCUS (Arcus Biosciences)?
Which analyst is the currently most reserved on RCUS (Arcus Biosciences)?